SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-074381
Filing Date
2022-11-22
Accepted
2022-11-22 07:00:28
Documents
33
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea168808-6k_kamadaltd.htm   iXBRL 6-K 22254
2 KAMADA REPORTS STRONG THIRD QUARTER FINANCIAL RESULTS DEMONSTRATING SUCCESSFUL S ea168808ex99-1_kamadaltd.htm EX-99.1 207804
3 KAMADA LTD'S CONSOLIDATED FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2022 (UNAUDIT ea168808ex99-2_kamadaltd.htm   iXBRL EX-99.2 649943
  Complete submission text file 0001213900-22-074381.txt   3021821

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE kmda-20220930.xsd EX-101.SCH 35032
5 XBRL CALCULATION FILE kmda-20220930_cal.xml EX-101.CAL 40519
6 XBRL DEFINITION FILE kmda-20220930_def.xml EX-101.DEF 107708
7 XBRL LABEL FILE kmda-20220930_lab.xml EX-101.LAB 262679
8 XBRL PRESENTATION FILE kmda-20220930_pre.xml EX-101.PRE 113849
27 EXTRACTED XBRL INSTANCE DOCUMENT ea168808-6k_kamadaltd_htm.xml XML 467201
Mailing Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402
Business Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402 97289406472
KAMADA LTD (Filer) CIK: 0001567529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35948 | Film No.: 221407450
SIC: 2834 Pharmaceutical Preparations